"Ultra-sensitive" cardiac troponins: Requirements for effective implementation in clinical practice
- PMID: 30429666
- PMCID: PMC6214691
- DOI: 10.11613/BM.2018.030501
"Ultra-sensitive" cardiac troponins: Requirements for effective implementation in clinical practice
Abstract
The measurement of cardiac troponins, either cardiac troponin I or T, has become the culprit of clinical decision making in patients with suspected acute coronary syndrome (ACS), especially in those with non-ST elevation myocardial infarction (NSTEMI). The leading analytical mainstays of cardiac troponin immunoassays include the limit of blank (LoB), limit of detection (LoD), functional sensitivity, the 99th percentile of a healthy reference population, along with the percentage of "ostensibly healthy" subjects displaying measurable values < 99th percentile. The latest generation of cardiac troponin immunoassays, conventionally defined as "high-sensitive" (HS), is characterized by a LoD over 100-fold lower compared to the first commercialized techniques and a percentage of measurable values consistently > 50% in the general healthy population. The very recent commercialization of methods with further improved analytical sensitivity (i.e., "ultra-sensitive" assays), which allow to measure cardiac troponin values in the vast majority of healthy subjects, is now challenging the diagnostic paradigm based on early rule-out of subjects with cardiac troponin values comprised between the 99th percentile and LoD. New diagnostic strategies, entailing assay-specific cut-offs, must hence be developed and validated in large multicenter studies. The aim of this article is to provide an update on commercially available HS and "ultra"-sensitive techniques for measuring cardiac troponins, along with possible implications of increasingly enhanced analytical sensitivity on diagnostic algorithms for evaluating patients with suspected ACS.
Keywords: acute coronary syndrome; cardiac troponin; diagnostics; myocardial infarction.
Conflict of interest statement
Potential conflict of interest: None declared.
Figures


Similar articles
-
High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification.Crit Rev Clin Lab Sci. 2017 May;54(3):143-172. doi: 10.1080/10408363.2017.1285268. Epub 2017 May 1. Crit Rev Clin Lab Sci. 2017. PMID: 28457177 Review.
-
Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care.Clin Chem. 2017 Jan;63(1):73-81. doi: 10.1373/clinchem.2016.255109. Epub 2016 Oct 10. Clin Chem. 2017. PMID: 28062612 Review.
-
Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome.Clin Chem. 2014 Jan;60(1):158-64. doi: 10.1373/clinchem.2013.206441. Epub 2013 Sep 19. Clin Chem. 2014. PMID: 24052087
-
Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency department.CMAJ. 2018 Aug 20;190(33):E974-E984. doi: 10.1503/cmaj.180144. CMAJ. 2018. PMID: 30127037 Free PMC article.
-
New sensitive cardiac troponin assays for the early diagnosis of myocardial infarction.Drugs Today (Barc). 2011 Apr;47(4):303-12. doi: 10.1358/dot.2011.47.4.1533082. Drugs Today (Barc). 2011. PMID: 21573253 Review.
Cited by
-
Cardiac troponin elevation in patients with influenza virus infections.Biomed J. 2021 Apr;44(2):183-189. doi: 10.1016/j.bj.2020.06.001. Epub 2020 Jun 10. Biomed J. 2021. PMID: 33097442 Free PMC article.
-
Ultra-high sensitivity cardiac troponin-I concentration and left ventricular structure and function in women with ischemia and no obstructive coronary artery disease.Am Heart J Plus. 2022 Jan;13:100115. doi: 10.1016/j.ahjo.2022.100115. Epub 2022 Mar 3. Am Heart J Plus. 2022. PMID: 35784010 Free PMC article.
-
Coronary Vascular Function and Cardiomyocyte Injury: A Report From the WISE-CVD.Arterioscler Thromb Vasc Biol. 2020 Dec;40(12):3015-3021. doi: 10.1161/ATVBAHA.120.314260. Epub 2020 Oct 8. Arterioscler Thromb Vasc Biol. 2020. PMID: 33028098 Free PMC article.
-
Comparison of ADVIA Centaur ultra-sensitive and high-sensitive assays for troponin I in serum.Pract Lab Med. 2022 Jul 12;31:e00293. doi: 10.1016/j.plabm.2022.e00293. eCollection 2022 Aug. Pract Lab Med. 2022. PMID: 35860388 Free PMC article.
-
Exploring the association between extra-cardiac troponin elevations and risk of future mortality.J Med Biochem. 2020 Oct 2;39(4):415-421. doi: 10.5937/jomb0-25262. J Med Biochem. 2020. PMID: 33312056 Free PMC article.
References
-
- Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267–315. 10.1093/eurheartj/ehv320 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials